172 related articles for article (PubMed ID: 37855385)
1. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
2. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
3. UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.
Xiang G; Wang S; Chen L; Song M; Song X; Wang H; Zhou P; Ma X; Yu J
Cell Death Dis; 2022 May; 13(5):451. PubMed ID: 35551175
[TBL] [Abstract][Full Text] [Related]
4. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
5.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
6. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
7. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
8. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
10. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
11. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
13. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
14. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
15. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
17. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
Gu YF; Ge XP
J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
[TBL] [Abstract][Full Text] [Related]
18. UBR5 promotes migration and invasion of glioma cells by regulating the ECRG4/NF-ҡB pathway.
Wu Q; Liu L; Feng Y; Wang L; Liu X; Li Y
J Biosci; 2022; 47():. PubMed ID: 36226349
[TBL] [Abstract][Full Text] [Related]
19. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
20. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
